H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

H. B. Fuller Company

Fulcrum Therapeutics ($FULC) announced an update on their ongoing clinical study. Fulcrum Therapeutics is launching an open-label extension study c...

Fulcrum Extends Pociredir Program With Long-Term Sickle Cell Study

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Taysha Gene Therapies (TSHA) and Fulcrum Therapeutic...

Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Fulcrum Therapeutics (FULC)

The latest update is out from Fulcrum Lithium Ltd. ( ($AU:FUL) ). Fulcrum Lithium Ltd. has released its interim financial statements for the half y...

Current Quarter	$1.37	Next Quarter	$1.42
Current Year	$4.77	Next Year	$5.39
QoQ Growth	+3.6%	YoY Growth	+13.0%
3Y EPS CAGR	-8.1%	Target Price	$70.14
Consensus	Buy	Upside	+11.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FUL	$62.82	+8.72%	408.63K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FUL	$62.82	+8.7%	408.63K
3
4
5
6

FUL

FUL

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get H. B. Fuller Company Data in Excel

Get H. B. Fuller Company Data in Excel